Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

1
Idiopathic Thrombocytopenic Purpura (ITP)
Therapeutics - Pipeline Assessment and Market
Forecasts to 2019

• Aarkstore Enterprise specialize in providing
  online market business information on market
  research reports, books, magazines, conference
  booking at competitive prices, and strive to
  provide excellent and innovative service to our
  customers.

2
Idiopathic Thrombocytopenic Purpura (ITP)
Therapeutics - Pipeline Assessment and Market
Forecasts to 2019

• Date 29 February 2012
• Pages 63
• SummaryCompany, the industry analysis
  specialist, has released its new report,
  Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics - Pipeline Assessment and Market
  Forecasts to 2019. The report is an essential
  source of information and analysis on the global
  Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market. The report identifies the
  key trends shaping and driving the global
  Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market. The report also provides
  insights on the prevalent competitive landscape
  and the emerging players expected to
  significantly alter the market positioning of the
  current market leaders. Most importantly, the
  report provides valuable insights on the pipeline
  products within the global Idiopathic
  Thrombocytopenic Purpura (ITP) Therapeutics
  sector. This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by Company team of industry
  experts.ScopeThe report provides information
  on the key drivers and challenges of the
  Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market. Its scope includes - -
  Annualized seven key markets (US, France,
  Germany, Italy, Spain, UK and Japan) Idiopathic
  Thrombocytopenic Purpura (ITP) Therapeutics
  market revenues data from 2006 to 2011, forecast
  for eight years to 2019. - Pipeline analysis
  data providing a split across the different
  phases, mechanisms of action being developed and
  emerging trends by seven key markets. Pipeline
  candidates fall under major therapeutic
  classes.- Analysis of the current and future
  competition in the seven key countries Idiopathic
  Thrombocytopenic Purpura (ITP) Therapeutics
  market. - Insightful review of the key industry
  drivers, restraints and challenges. Each trend is
  independently researched to provide a qualitative
  analysis of its implications. - Key topics
  covered include strategic competitor assessment,
  market characterization, unmet needs and the
  implications for the Idiopathic Thrombocytopenic
  Purpura (ITP) Therapeutics market.- Analysis of
  key recent licensing and partnership agreements
  in Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market

3
Clostridium difficile Infection (CDI)
Therapeutics - Pipeline Assessment and Market
Forecasts to 2019

• Reasons to buyThe report will enhance your
  decision making capability. It will allow you to
  - - Develop and design your in-licensing and
  out-licensing strategies through a review of
  pipeline products and technologies and by
  identifying the companies with the most robust
  pipeline. - Develop business strategies by
  understanding the trends shaping and driving the
  global Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market. - Drive revenues by
  understanding the key trends, innovative products
  and technologies, market segments and companies
  likely to impact the global Idiopathic
  Thrombocytopenic Purpura (ITP) Therapeutics
  market in future. - Formulate effective sales
  and marketing strategies by understanding the
  competitive landscape and by analyzing the
  performance of various competitors. - Identify
  emerging players with potentially strong product
  portfolios and create effective
  counter-strategies to gain a competitive
  advantage. - Organize your sales and marketing
  efforts by identifying the market categories and
  segments that present maximum opportunities for
  consolidations, investments and strategic
  partnerships. - What the next big thing in the
  global Idiopathic Thrombocytopenic Purpura (ITP)
  Therapeutics market landscape? Identify,
  understand and capitalize.

4
1.1 List of Tables 51.2 List of Figures 62
Idiopathic Thrombocytopenic Purpura (ITP)
Therapeutics - Introduction 72.1 Overview 72.2
Classification of Idiopathic Thrombocytopenic
Purpura 72.3 Pathophysiology of Chronic
Idiopathic Thrombocytopenic Purpura 82.4
Epidemiology 92.5 Clinical Symptoms 92.6
Diagnosis and Management of Idiopathic
Thrombocytopenic Purpura 92.7 Treatment of
Idiopathic Thrombocytopenic Purpura 112.8
GlobalData Pipeline Report Guidance 123
Idiopathic Thrombocytopenic Purpura Therapeutics
- Market Characterization 133.1 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - Global 133.2 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - Global 143.3 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - the US 153.4 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - the US 163.5 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - the UK 173.6 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - the UK 183.7 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - France 193.8 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - France 203.9 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - Germany 213.10 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - Germany 223.11 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - Italy 233.12 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - Italy 243.13 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - Spain 253.14 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - Spain 263.15 Idiopathic
Thrombocytopenic Purpura Therapeutics Market Size
(2006-2011) - Japan 273.16 Idiopathic
Thrombocytopenic Purpura Therapeutics Market
Forecast (2011-2019) - Japan 283.16.1 Drivers
for the Idiopathic Thrombocytopenic Purpura
Therapeutics Market 293.16.2 Barriers for the
Idiopathic Thrombocytopenic Purpura Therapeutics
Market 293.17 Key Events Impacting the Future
Market 303.18 Opportunity and Unmet Need 313.19
Key Takeaway 32
5

4 Idiopathic Thrombocytopenic Purpura
Therapeutics Market - Competitive Assessment
334.1 Overview 334.2 Strategic Competitor
Assessment 334.3 Product Profiles for the Major
Marketed Products in the Idiopathic
Thrombocytopenic Purpura Therapeutics Market
344.3.1 Nplate (romiplostim) 344.3.2
Promacta/Revolade (eltrombopag) 344.4 Key
Takeaway 355 Idiopathic Thrombocytopenic Purpura
Therapeutics Market - Pipeline Assessment 365.1
Overview 365.1.1 Strategic Pipeline Assessment
365.2 Idiopathic Thrombocytopenic Purpura
Therapeutics Pipeline Analysis - Pipeline by
Clinical Phases of Development 365.2.1 ITP
Therapeutics - Phase III Clinical Pipeline
365.2.2 Idiopathic Thrombocytopenic Purpura
Therapeutics - Phase II Clinical Pipeline
375.2.3 Idiopathic Thrombocytopenic Purpura
Therapeutics - Phase I/II Clinical Pipeline
375.2.4 Idiopathic Thrombocytopenic Purpura
Therapeutics - Pre-Clinical Pipeline 375.3
Idiopathic Thrombocytopenic Purpura Therapeutics
Market - Clinical Pipeline by Mechanism of Action
385.4 Idiopathic Thrombocytopenic Purpura
Technology Trends Analytical Framework 395.5
Molecule Profile for Late-Stage Drugs under
Clinical Development 405.5.1 IGIV3I 10 Grifols
405.5.2 Mabthera (rituximab) 415.6 Key Takeaway
416 Idiopathic Thrombocytopenic Purpura
Therapeutics - Clinical Trials Mapping 426.1
Clinical Trials by Country 426.2 Clinical Trials
by Phase 436.3 Clinical Trials by Trial Status
446.4 Overall Sponsors 456.5 Prominent Sponsors
466.6 Top Companies Participating in Idiopathic
Thrombocytopenic Purpura Therapeutics Clinical
Trials 47
6

7 Idiopathic Thrombocytopenic Purpura
Therapeutics - Strategic Assessment 487.1 Future
Market Competition Scenario 488 Idiopathic
Thrombocytopenic Purpura Therapeutics - Future
Players 498.1 Introduction 498.2 Company
Profiles 508.2.1 F. Hoffmann-La Roche 508.2.2
Grifols Biologicals Inc. 518.2.3 Amgen Inc.
518.2.4 GlaxoSmithKline plc 538.2.5 Other
Companies in the Idiopathic Thrombocytopenic
Purpura Therapeutics Market, 2011 559 Idiopathic
Thrombocytopenic Purpura Therapeutics - Licensing
and Partnership Deals 5610 Idiopathic
Thrombocytopenic Purpura Therapeutics - Appendix
5710.1 Definitions 5710.2 Acronyms 5710.3
Research Methodology 5810.3.1 Coverage 5810.3.2
Secondary Research 5810.3.3 Forecasting
5910.3.4 Primary Research 6110.3.5 Expert Panel
Validation 6210.4 Contact Us 6210.5 Disclaimer
6210.6 Bibliography 62 
7

• For more information, please visit
• http//www.aarkstore.com/reports/Idiopathic-Thromb
  ocytopenic-Purpura-ITP-Therapeutics-Pipeline-Asses
  sment-and-Market-Forecasts-to-2019-198832.htmlOr
  email us at contact_at_aarkstore.com or call
  919272852585
• Related Reports
• Vemurafenib - Comprehensive patent
  search Colesevelam - Comprehensive patent
  search Rifaximin - Comprehensive patent
  search Nevirapine - Comprehensive patent
  search Liraglutide - Comprehensive patent
  search Vilazodone - Comprehensive patent
  search Hexylaminolevulinic Acid - Comprehensive
  patent search Treprostinil - Comprehensive
  patent search Patient Adherence, Communication
  and Engagement (PACE) - Increased Investment and
  Adoption of New Digital Tools Enable Key
  Stakeholder Collaborations and Encourage
  Compliance Express Scripts, Inc.
  Pharmaceuticals and Healthcare Company Profile,
  SWOT and Financial Report

8
Contact Us

• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise